Follow-The-Filings

Security · featured owners

NDAQ Ishares Nasdaq Biotech Indx

Financials ETF Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 1.5%
  • $8M
  • 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 1.5% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel reduce 1.5%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 1.5% Reduce −31.4% 42,595 $8M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,7.01,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,1.02,2.03,9.01 Filing Doc
8-K 5.07 Filing Doc
DEFA14A Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Aug 10, 2026 · 2 forms Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Aug 3, 2026 Filing Doc
4 Period Jul 29, 2026 Filing Doc
4 Period Jul 24, 2026 · 2 forms Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 11, 2026 · 2 forms Filing Doc
4 Period Jun 10, 2026 · 11 forms Filing Doc
4 Period May 18, 2026 Filing Doc
4 Period Apr 28, 2026 Filing Doc
4 Period Apr 27, 2026 Filing Doc
4 Period Apr 24, 2026 Filing Doc

Updated about 17 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6.06B $7.4B $8.26B
Gross profit $3.9B $4.65B $5.25B
Gross margin * 64.2% 62.8% 63.5%
Net income $1.06B $1.12B $1.79B
Net margin * 17.5% 15.1% 21.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $9.1B $7.79B $8B
Total non-current assets * $23.2B $22.61B $23.05B
Total assets $32.29B $30.4B $31.05B
Total current liabilities $9.02B $7.9B $7.96B
Total non-current liabilities * $12.44B $11.29B $10.86B
Total equity $10.82B $11.19B $12.23B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.7B $1.94B $2.26B
Cash from investing -$5.99B -$0.953B -$1.1B
Cash from financing $4.22B -$2.56B -$2.95B
Net change in cash $0.124B -$2.11B -$1.07B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders